Home The Word Brain My Amedeo FAQ Privacy About


Hanzi Hunter

Learning 500 Chinese characters in 30 days is possible.

Abstract • About

  Andrology

  Free Subscription


Articles published in J Urol

Retrieve available abstracts of 206 articles:
HTML format



Single Articles


    April 2026
  1. AL HOMSI A, Raheem OA
    Letter: Cross-Sectional Association of Time Spent Outdoors With Serum Testosterone: Results From the National Health and Nutrition Examination Survey.
    J Urol. 2026;215:472.
    PubMed    


    March 2026
  2. RITCH CR
    Urologic Oncology: Bladder, Penis, and Urethral Cancer and Basic Principles of Oncology.
    J Urol. 2026 Mar 10:101097JU0000000000005010. doi: 10.1097/JU.0000000000005010.
    PubMed    


  3. KAPLAN SA
    Benign Prostatic Hyperplasia.
    J Urol. 2026 Mar 6:101097JU0000000000005009. doi: 10.1097/JU.0000000000005009.
    PubMed    


  4. LIN YH
    Reply: A New Framework for Testosterone Deficiency: Integrating Organ-Specific and Circadian Thresholds.
    J Urol. 2026;215:348-349.
    PubMed    


  5. LOUGHLIN KR
    Letter: A New Framework for Testosterone Deficiency: Integrating Organ-Specific and Circadian Thresholds.
    J Urol. 2026;215:347.
    PubMed    


    February 2026
  6. MURRAY DP, Dietrich PN, Sandlow JI
    Advancing Vasectomy Care: Reflections on the 2026 AUA Guideline Updates, Clinical Implications, and Research Priorities.
    J Urol. 2026 Feb 20:101097JU0000000000005008. doi: 10.1097/JU.0000000000005008.
    PubMed    


  7. LAWEN T, Garcia RS, Smith MT, Pyo J, et al
    Low Testosterone Levels and Grade Group Progression Among Localized Prostate Cancer Patients on Active Surveillance: A Retrospective Cohort Study.
    J Urol. 2026 Feb 9:101097JU0000000000004986. doi: 10.1097/JU.0000000000004986.
    PubMed     Abstract available


  8. POLLOCK NL, Chang J, Onishi E, Chatton A, et al
    Effectiveness and complications of vasectomy with fascial interposition without mucosal cautery: a retrospective cohort study.
    J Urol. 2026 Feb 9:101097JU0000000000004984. doi: 10.1097/JU.0000000000004984.
    PubMed     Abstract available


  9. RITCH CR
    Urologic Oncology: Bladder, Penis, and Urethral Cancer and Basic Principles of Oncology.
    J Urol. 2026 Feb 3:101097JU0000000000004946. doi: 10.1097/JU.0000000000004946.
    PubMed    


    January 2026
  10. SCHLEGEL PN, Vij SC, Filson C, Penzo-Mendez A, et al
    Vasectomy and the Risk of Prostate Cancer.
    J Urol. 2026 Jan 20:101097JU0000000000004937. doi: 10.1097/JU.0000000000004937.
    PubMed    


  11. MORGENTALER A, Traish AM
    TESTOSTERONE DOES NOT DRIVE PROSTATE CANCER: PRESENTING THE NEW FRAMEWORK OF ANDROGEN ADEQUACY VERSUS INADEQUACY.
    J Urol. 2026 Jan 13:101097JU0000000000004936. doi: 10.1097/JU.0000000000004936.
    PubMed     Abstract available


  12. SHIRAISHI K, Tokitaka S, Ban Y, Oka S, et al
    Long-Term Outcomes of Varicocelectomy in Children and Adolescents: Impact of Timing on Testicular Growth and Spermatogenesis.
    J Urol. 2026 Jan 13:101097JU0000000000004934. doi: 10.1097/JU.0000000000004934.
    PubMed     Abstract available


    December 2025
  13. RITCH CR
    Urologic Oncology: Bladder, Penis, and Urethral Cancer, and Basic Principles of Oncology.
    J Urol. 2025 Dec 19:101097JU0000000000004884. doi: 10.1097/JU.0000000000004884.
    PubMed    


  14. RITCH CR
    Urologic Oncology: Bladder, Penis, and Urethral Cancer, and Basic Principles of Oncology.
    J Urol. 2025 Dec 16:101097JU0000000000004885. doi: 10.1097/JU.0000000000004885.
    PubMed    


  15. KAPLAN SA, Parekattil SJ, Wu NZ, Mazzarella B, et al
    12-Month Outcomes from a Randomized, Sham Controlled Trial Evaluating a Novel Prostatic Urethral Stent for the Treatment of Benign Prostatic Hyperplasia.
    J Urol. 2025 Dec 15:101097JU0000000000004896. doi: 10.1097/JU.0000000000004896.
    PubMed     Abstract available


  16. SCHLEGEL PN, Clark JY, Coward RM, Hirshberg SJ, et al
    Fertility Restoration After Vasectomy: AUA Guideline Part II.
    J Urol. 2025 Dec 9:101097JU0000000000004862. doi: 10.1097/JU.0000000000004862.
    PubMed     Abstract available


  17. SCHLEGEL PN, Clark JY, Coward RM, Hirshberg SJ, et al
    Vasectomy: AUA Guideline Part I.
    J Urol. 2025 Dec 9:101097JU0000000000004861. doi: 10.1097/JU.0000000000004861.
    PubMed     Abstract available


  18. BHAMBHVANI HP, Kuchakulla M, Poppas P, Greenberg DR, et al
    Reply: Cross-Sectional Association of Time Spent Outdoors With Serum Testosterone: Results From National Health and Nutrition Examination Survey.
    J Urol. 2025 Dec 9:101097JU0000000000004868. doi: 10.1097/JU.0000000000004868.
    PubMed    


  19. MCKIE KA, Moturu A, Graham DA, Coleman M, et al
    Antibiotic Prophylaxis Use and Outcomes in Children Undergoing Laparoscopic Orchiopexy.
    J Urol. 2025;214:622-630.
    PubMed     Abstract available


    November 2025
  20. LIN YH, Chen JY, Chen CL
    Letter: Cross-Sectional Association of Time Spent Outdoors With Serum Testosterone: Results From the National Health and Nutrition Examination Survey.
    J Urol. 2025 Nov 20:101097JU0000000000004798. doi: 10.1097/JU.0000000000004798.
    PubMed    


  21. BHAMBHVANI HP, Kuchakulla M, Poppas PJ, Greenberg DR, et al
    Reply: Cross-Sectional Association of Time Spent Outdoors With Serum Testosterone: Results From the National Health and Nutrition Examination Survey.
    J Urol. 2025 Nov 20:101097JU0000000000004810. doi: 10.1097/JU.0000000000004810.
    PubMed    


  22. MOUSA A, Chavarriaga J, Kaushal S, Burrafato Z, et al
    Primary Retroperitoneal Lymph Node Dissection in Marker Positive Clinical Stage II Non-Seminomatous Germ Cell Tumours.
    J Urol. 2025 Nov 10:101097JU0000000000004847. doi: 10.1097/JU.0000000000004847.
    PubMed     Abstract available


    October 2025
  23. RITCH CR
    Urologic Oncology: Bladder, Penis, and Urethral Cancer and Basic Principles of Oncology.
    J Urol. 2025 Oct 29:101097JU0000000000004809. doi: 10.1097/JU.0000000000004809.
    PubMed    


    September 2025
  24. DAVIS MF, Nikolavsky D, Cavalcanti AG, Flynn BJ, et al
    Multicenter Analysis of Long-Term Outcomes of Artificial Urinary Sphincter Surgery Following Urethroplasty.
    J Urol. 2025 Sep 29:101097JU0000000000004794. doi: 10.1097/JU.0000000000004794.
    PubMed     Abstract available


  25. KAPLAN SA
    Benign Prostatic Hyperplasia.
    J Urol. 2025 Sep 29:101097JU0000000000004775. doi: 10.1097/JU.0000000000004775.
    PubMed    


  26. BHAMBHVANI HP, Kuchakulla M, Poppas P, Greenberg DR, et al
    Cross-Sectional Association of Time Spent Outdoors with Serum Testosterone: Results from NHANES.
    J Urol. 2025 Sep 19:101097JU0000000000004789. doi: 10.1097/JU.0000000000004789.
    PubMed     Abstract available


  27. RITCH CR
    Urologic Oncology: Bladder, Penis, and Urethral Cancer and Basic Principles of Oncology.
    J Urol. 2025 Sep 11:101097JU0000000000004754. doi: 10.1097/JU.0000000000004754.
    PubMed    


  28. RITCH CR
    Urologic Oncology: Bladder, Penis, and Urethral Cancer, and Basic Principles of Oncology.
    J Urol. 2025 Sep 2:101097JU0000000000004710. doi: 10.1097/JU.0000000000004710.
    PubMed    


  29. HU B, Alsyouf M, Farkouh A, Cary C, et al
    Accuracy of 18F-Fluorodeoxyglucose Positron Emission Tomography in Early Metastatic Testicular Seminoma: Analysis From the SEMS Trial.
    J Urol. 2025;214:272-279.
    PubMed     Abstract available


    August 2025
  30. VAVILOV S, Nolan E, Pockney P, Smith GH, et al
    Long-term risk of reoperation following hypospadias surgery in childhood: a data-linkage study.
    J Urol. 2025 Aug 12:101097JU0000000000004715. doi: 10.1097/JU.0000000000004715.
    PubMed     Abstract available


  31. LAI HH, Pontari MA, Argoff CE, Bresler L, et al
    Male Chronic Pelvic Pain: AUA Guideline: Part I Evaluation and Management Approach.
    J Urol. 2025;214:116-126.
    PubMed     Abstract available


  32. LAI HH, Pontari MA, Argoff CE, Bresler L, et al
    Male Chronic Pelvic Pain: AUA Guideline: Part II Treatment of Chronic Prostatitis/Chronic Pelvic Pain Syndrome.
    J Urol. 2025;214:127-137.
    PubMed     Abstract available


    July 2025
  33. LIN YH, Chen JY, Wu CT
    A New Framework for Testosterone Deficiency: Integrating Organ-Specific and Circadian Thresholds.
    J Urol. 2025 Jul 24:101097JU0000000000004692. doi: 10.1097/JU.0000000000004692.
    PubMed    


  34. MATULEWICZ RS, Assel M, Vickers AJ, Jayalath VH, et al
    Performance characteristics of an analytic model predicting retroperitoneal lymph node dissection pathology following first-line chemotherapy for patients with metastatic non-seminomatous germ cell tumors.
    J Urol. 2025 Jul 7:101097JU0000000000004668. doi: 10.1097/JU.0000000000004668.
    PubMed    


  35. LEWER O, Felice MD, Copelan O, Janakiraman S, et al
    Prostate Size and Its Effect on Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia Improvement After Convective Water Vapor Thermal Therapy.
    J Urol. 2025;214:48-57.
    PubMed     Abstract available


  36. KAPLAN SA
    Benign Prostatic Hyperplasia.
    J Urol. 2025 Jul 1:101097JU0000000000004640. doi: 10.1097/JU.0000000000004640.
    PubMed    


    June 2025
  37. ZENG J, McFadden J, Thakker P, Tachibana I, et al
    Retroperitoneal Nodal Distribution for Metastatic Seminoma: Is Modified Template Appropriate? A Retrospective Study.
    J Urol. 2025;213:753-765.
    PubMed     Abstract available


    May 2025
  38. DIETRICH P, Werner Z
    Editorial Comment: A Prospective Randomized Study on Low-Energy Extracorporeal Shockwave Therapy (LI-SWT) for Erectile Dysfunction After Radical Prostatectomy.
    J Urol. 2025 May 23:101097JU0000000000004609. doi: 10.1097/JU.0000000000004609.
    PubMed    


  39. DMOCHOWSKI R
    Editorial Comment: A Prospective Randomized Study on Low-Energy Extracorporeal Shockwave Therapy (LI-SWT) for Erectile Dysfunction After Radical Prostatectomy.
    J Urol. 2025 May 23:101097JU0000000000004607. doi: 10.1097/JU.0000000000004607.
    PubMed    


  40. JEFFERY J, Punjani N
    Editorial Comment on "A Prospective Randomized Study on Low-Energy Extracorporeal Shockwave Therapy (LI-SWT) for Erectile Dysfunction After Radical Prostatectomy".
    J Urol. 2025 May 23:101097JU0000000000004608. doi: 10.1097/JU.0000000000004608.
    PubMed    


    April 2025
  41. KAPLAN SA
    Benign Prostatic Hyperplasia.
    J Urol. 2025 Apr 29:101097JU0000000000004572. doi: 10.1097/JU.0000000000004572.
    PubMed    


  42. COPLEN DE
    Editorial Comment: Re: Utility of Preoperative Antimicrobial Prophylaxis in Hypospadias Repair: Results from NSQIP-Pediatric.
    J Urol. 2025 Apr 28:101097JU0000000000004575. doi: 10.1097/JU.0000000000004575.
    PubMed    


  43. DOERSCH KM, Diamond DA
    Utility of Preoperative Antimicrobial Prophylaxis in Hypospadias Repair: Results From NSQIP-Pediatrics.
    J Urol. 2025 Apr 28:101097JU0000000000004574. doi: 10.1097/JU.0000000000004574.
    PubMed    


  44. PEDERSEN TB, Secher C, Moumneh A, Hvid N, et al
    A Prospective Randomized Study on Low-Energy Extracorporeal Shockwave Therapy for Erectile Dysfunction After Radical Prostatectomy.
    J Urol. 2025 Apr 28:101097JU0000000000004576. doi: 10.1097/JU.0000000000004576.
    PubMed     Abstract available


  45. LAI HH, Pontari MA, Argoff CE, Bresler L, et al
    Male Chronic Pelvic Pain: AUA Guideline: Part III Treatment of Chronic Scrotal Content Pain.
    J Urol. 2025 Apr 17:101097JU0000000000004566. doi: 10.1097/JU.0000000000004566.
    PubMed     Abstract available


  46. CHANG SS
    Urologic Oncology: Bladder, Penis, and Urethral Cancer and Basic Principles of Oncology.
    J Urol. 2025 Apr 8:101097JU0000000000004543. doi: 10.1097/JU.0000000000004543.
    PubMed    


  47. BASIN MF, Gopalakrishnan M, Ackerman N, Mason MD, et al
    Utility of Preoperative Antimicrobial Prophylaxis in Hypospadias Repair: Results From NSQIP-Pediatrics.
    J Urol. 2025 Apr 3:101097JU0000000000004558. doi: 10.1097/JU.0000000000004558.
    PubMed     Abstract available


    March 2025
  48. CHANG SS
    Urologic Oncology: Bladder, Penis, and Urethral Cancer, and Basic Principles of Oncology.
    J Urol. 2025 Mar 27:101097JU0000000000004520. doi: 10.1097/JU.0000000000004520.
    PubMed    


  49. NI X, Sui J, Wang B, Wang H, et al
    Lower Testosterone level and metastases-free survival in nmCRPC patients treated with novel antiandrogens: A post-hoc analysis of SPARTAN and ARAMIS.
    J Urol. 2025 Mar 25:101097JU0000000000004545. doi: 10.1097/JU.0000000000004545.
    PubMed     Abstract available


    February 2025
  50. CHANG SS
    Urologic Oncology: Bladder, Penis, and Urethral Cancer and Basic Principles of Oncology.
    J Urol. 2025 Feb 26:101097JU0000000000004479. doi: 10.1097/JU.0000000000004479.
    PubMed    


  51. CHANG SS
    Urologic Oncology: Bladder, Penis, and Urethral Cancer and Basic Principles of Oncology.
    J Urol. 2025 Feb 21:101097JU0000000000004389. doi: 10.1097/JU.0000000000004389.
    PubMed    


  52. KAPLAN SA
    Benign Prostatic Hyperplasia.
    J Urol. 2025 Feb 17:101097JU0000000000004471. doi: 10.1097/JU.0000000000004471.
    PubMed    


  53. PANDIT K, Morgan K, Riviere P, Dabbas M, et al
    Reply: Incidence of Erectile Dysfunction and Testosterone Deficiency in Testicular Cancer Survivors.
    J Urol. 2025 Feb 12:101097JU0000000000004461. doi: 10.1097/JU.0000000000004461.
    PubMed    


  54. HINOJOSA-GONZALEZ DE
    Letter: Comparative Analysis of Holmium Laser Enucleation of the Prostate and Robotic-Assisted Simple Prostatectomy in Benign Prostatic Hyperplasia Management: A Systematic Review and Meta-Analysis.
    J Urol. 2025 Feb 10:101097JU0000000000004454. doi: 10.1097/JU.0000000000004454.
    PubMed    


  55. WANG W, Gao C, Fu K
    Letter: Incidence of Erectile Dysfunction and Testosterone Deficiency in Testicular Cancer Survivors.
    J Urol. 2025 Feb 3:101097JU0000000000004440. doi: 10.1097/JU.0000000000004440.
    PubMed    


  56. BENZOUAK T, Addar A, Prudencio-Brunello MA, Saed Aldien A, et al
    Comparative Analysis of Holmium Laser Enucleation of the Prostate and Robotic-Assisted Simple Prostatectomy in Benign Prostatic Hyperplasia Management: A Systematic Review and Meta-Analysis.
    J Urol. 2025;213:150-161.
    PubMed     Abstract available


  57. CHANG SS
    Urologic Oncology: Bladder, Penis, and Urethral Cancer, and Basic Principles of Oncology.
    J Urol. 2025;213:264-265.
    PubMed    


    January 2025
  58. CHANG SS
    Urologic Oncology: Bladder, Penis, and Urethral Cancer and Basic Principles of Oncology.
    J Urol. 2025 Jan 23:101097JU0000000000004418. doi: 10.1097/JU.0000000000004418.
    PubMed    


  59. HENGEL R, Vanni A, Erickson B, Elliott S, et al
    Multi-Institutional Analysis of Surgery for Lichen Sclerosus Induced Penile Urethral Stricture: Establishing Single-Stage Urethroplasty as a Primary Treatment Option.
    J Urol. 2025 Jan 21:101097JU0000000000004434. doi: 10.1097/JU.0000000000004434.
    PubMed     Abstract available


  60. ABBASI B, Hacker E, Ghaffar U, Hakam N, et al
    Higher Morbidity and Mortality in Females With Fournier Gangrene Compared With Males: Insights From National Inpatient Sample Data.
    J Urol. 2025;213:99-109.
    PubMed     Abstract available


    December 2024
  61. HA A, Zhang CA, Li S, Langroudi AP, et al
    A Contemporary Estimate of Vasectomy Failure in the United States: Analysis of US Claims Data.
    J Urol. 2024 Dec 31:101097JU0000000000004405. doi: 10.1097/JU.0000000000004405.
    PubMed     Abstract available


  62. CHANG SS
    Urologic Oncology: Bladder, Penis, and Urethral Cancer and Basic Principles of Oncology.
    J Urol. 2024 Dec 11:101097JU0000000000004349. doi: 10.1097/JU.0000000000004349.
    PubMed    


  63. ERICKSON BA, Tuong MN, Zorn AN, Schlaepfer CH, et al
    Development and Validation of the Length, Segment, and Etiology (LSE) Anterior Urethral Stricture Disease Staging System Using Longitudinal Urethroplasty Outcomes Data from the Trauma and Urologic Reconstruction Network of Surgeons.
    J Urol. 2024 Dec 9:101097JU0000000000004369. doi: 10.1097/JU.0000000000004369.
    PubMed     Abstract available


  64. KAPLAN SA
    Benign Prostatic Hyperplasia.
    J Urol. 2024 Dec 9:101097JU0000000000004345. doi: 10.1097/JU.0000000000004345.
    PubMed    


  65. LEUNBACH TL, Berglund A, Ernst A, Hvistendahl GM, et al
    Prevalence, Incidence, and Age at Diagnosis of Boys With Hypospadias: A Nationwide Population-Based Epidemiological Study.
    J Urol. 2024 Dec 3:101097JU0000000000004319. doi: 10.1097/JU.0000000000004319.
    PubMed     Abstract available


  66. GREENBERG DR, Gago LC, Kumar SKSR, Panken EJ, et al
    Epididymal Cyst Lesions Are Not Associated With Impaired Semen Parameters Among Men Presenting for Fertility Evaluation.
    J Urol. 2024;212:891-898.
    PubMed     Abstract available


  67. BRANNIGAN RE, Hermanson L, Kaczmarek J, Kim SK, et al
    Updates to Male Infertility: AUA/ASRM Guideline (2024).
    J Urol. 2024;212:789-799.
    PubMed     Abstract available


  68. KAPLAN SA
    Benign Prostatic Hyperplasia.
    J Urol. 2024;212:924-926.
    PubMed    


    November 2024
  69. CHANG SS
    Urologic Oncology: Bladder, Penis, and Urethral Cancer and Basic Principles of Oncology.
    J Urol. 2024 Nov 20:101097JU0000000000004320. doi: 10.1097/JU.0000000000004320.
    PubMed    


  70. NESTLER T, Heidenreich A
    Letter: Eleven-Year Experience With Midline Extraperitoneal Retroperitoneal Lymph Node Dissection for Germ Cell Tumors.
    J Urol. 2024 Nov 5:101097JU0000000000004304. doi: 10.1097/JU.0000000000004304.
    PubMed    


  71. CHANG SS
    Urological Oncology: Bladder, Penis, and Urethra Cancer, and Basic Principles of Oncology.
    J Urol. 2024;212:779-780.
    PubMed    


    October 2024
  72. CHANG SS
    Urologic Oncology: Bladder, Penis, and Urethral Cancers and Basic Principles of Oncology.
    J Urol. 2024 Oct 24:101097JU0000000000004288. doi: 10.1097/JU.0000000000004288.
    PubMed    


  73. STASKIN D, Owens-Grillo J, Thomas E, Rovner E, et al
    Reply: Letter: Efficacy and Safety of Vibegron for Persistent Symptoms of Overactive Bladder in Men Being Pharmacologically Treated for Benign Prostatic Hyperplasia: Results From the Phase 3 COURAGE Trial.
    J Urol. 2024 Oct 23:101097JU0000000000004291. doi: 10.1097/JU.0000000000004291.
    PubMed    


  74. CHANG SS
    Urologic Oncology: Bladder, Penis, and Urethral Cancer, and Basic Principles of Oncology.
    J Urol. 2024 Oct 8:101097JU0000000000004240. doi: 10.1097/JU.0000000000004240.
    PubMed    


  75. NIEDERBERGER C
    Male Infertility.
    J Urol. 2024;212:633-635.
    PubMed    


  76. CHANG SS
    Urologic Oncology: Bladder, Penis, and Urethral Cancer, and Basic Principles of Oncology.
    J Urol. 2024;212:639-640.
    PubMed    


    September 2024
  77. FLORES JM, Vertosick EA, Salter CA, Benfante N, et al
    Testosterone Therapy in Men After Radical Prostatectomy for Organ-Confined, Low-Intermediate Prostate Cancer.
    J Urol. 2024 Sep 30:101097JU0000000000004267. doi: 10.1097/JU.0000000000004267.
    PubMed     Abstract available


  78. PANDIT K, Riviere P, Morgan K, Nelson T, et al
    Incidence of Erectile Dysfunction and Testosterone Deficiency in Testicular Cancer Survivors.
    J Urol. 2024 Sep 30:101097JU0000000000004259. doi: 10.1097/JU.0000000000004259.
    PubMed     Abstract available


  79. DIECKMANN KP, Belge G
    Letter: miR-371a-3p Predicting Viable Tumor in Patients Undergoing Retroperitoneal Lymph Node Dissection for Metastatic Testicular Cancer: The SWENOTECA-MIR Study.
    J Urol. 2024 Sep 17:101097JU0000000000004241. doi: 10.1097/JU.0000000000004241.
    PubMed    


  80. ALSYOUF M, Ghoreifi A, Ashrafi A, Ladi-Seyedian SS, et al
    11-Year Experience With Midline Extraperitoneal Retroperitoneal Lymph Node Dissection for Germ Cell Tumors.
    J Urol. 2024 Sep 13:101097JU0000000000004246. doi: 10.1097/JU.0000000000004246.
    PubMed     Abstract available


  81. TROST L, Mulhall J, Hellstrom W
    Creation of a Novel Classification System (PTNM) for Peyronie's Disease and Penile Curvature Using Evidence-Based Criteria.
    J Urol. 2024;212:470-482.
    PubMed     Abstract available


    August 2024
  82. CHANG SS
    Urologic Oncology: Bladder, Penis, and Urethral Cancer, and Basic Principles of Oncology.
    J Urol. 2024 Aug 22:101097JU0000000000004206. doi: 10.1097/JU.0000000000004206.
    PubMed    


  83. YU T, Yang Y, Shan D, Li J, et al
    Letter: Efficacy and Safety of Vibegron for Persistent Symptoms of Overactive Bladder in Men Being Pharmacologically Treated for Benign Prostatic Hyperplasia: Results From the Phase 3 Randomized Controlled COURAGE Trial.
    J Urol. 2024 Aug 22:101097JU0000000000004200. doi: 10.1097/JU.0000000000004200.
    PubMed    


  84. KAPLAN SA
    Benign Prostatic Hyperplasia.
    J Urol. 2024 Aug 20:101097JU0000000000004211. doi: 10.1097/JU.0000000000004211.
    PubMed    


  85. GU C, Belarmino A, Kenfield SA, Nolte D, et al
    Post-Vasectomy Semen Analysis Compliance With Utilization of a Mail-In Semen Analysis Kit.
    J Urol. 2024 Aug 2:101097JU0000000000004185. doi: 10.1097/JU.0000000000004185.
    PubMed     Abstract available


  86. NIEDERBERGER C
    Male Infertility.
    J Urol. 2024;212:386-388.
    PubMed    


  87. PATEL HV, Li KD, Rourke K, Smith TG 3rd, et al
    The Impact of Social Deprivation on Anterior Urethral Stricture Recurrence After Urethroplasty - A Trauma and Urologic Reconstructive Network of Surgeons (TURNS) Analysis.
    J Urol. 2024 Aug 1:101097JU0000000000004188. doi: 10.1097/JU.0000000000004188.
    PubMed     Abstract available


  88. KAPLAN SA
    Benign Prostatic Hyperplasia.
    J Urol. 2024;212:381-384.
    PubMed    


    July 2024
  89. ALSYOUF M, Daneshmand S
    Moving the Needle in Early Stage Testicular Germ Cell Tumor Management: The MAGESTIC Trial.
    J Urol. 2024 Jul 31:101097JU0000000000004182. doi: 10.1097/JU.0000000000004182.
    PubMed    


  90. THOR A, Myklebust MP, Bergdahl AG, Lundgren PO, et al
    miR-371a-3p Predicting Viable Tumor in Patients Undergoing RPLND for Metastatic Testicular Cancer: The SWENOTECA-MIR Study.
    J Urol. 2024 Jul 25:101097JU0000000000004164. doi: 10.1097/JU.0000000000004164.
    PubMed     Abstract available


  91. CHANG SS
    Urological Oncology: Bladder, Penis and Urethra Cancer, and Basic Principles of Oncology.
    J Urol. 2024 Jul 25:101097JU0000000000004153. doi: 10.1097/JU.0000000000004153.
    PubMed    


  92. BATUR AF, Altintas E, Gul M
    Letter: Efficacy and Safety of Vibegron for Persistent Symptoms of Overactive Bladder in Men Being Pharmacologically Treated for Benign Prostatic Hyperplasia: Results From the Phase 3 Randomized Controlled COURAGE Trial.
    J Urol. 2024 Jul 25:101097JU0000000000004156. doi: 10.1097/JU.0000000000004156.
    PubMed    


  93. CHANG SS
    Urological Oncology: Bladder, Penis, and Urethra Cancer, and Basic Principles of Oncology.
    J Urol. 2024 Jul 25:101097JU0000000000004120. doi: 10.1097/JU.0000000000004120.
    PubMed    


  94. LAZAROVICH A, Dahmen AS, Modi PK, Agarawal PK, et al
    Urologic Oncology: Bladder, Penis, and Urethral Cancer, and Basic Principles of Oncology.
    J Urol. 2024;212:236-237.
    PubMed    


  95. NIEDERBERGER C
    Male Infertility.
    J Urol. 2024;212:247-248.
    PubMed    


  96. KAPLAN SA
    BPH.
    J Urol. 2024;212:241-243.
    PubMed    


  97. HAYON S, Kumar SKS, Greenberg D, Mi X, et al
    Distribution and Positive Predictive Value of Follicle Stimulating Hormone Among Nonazoospermic Men.
    J Urol. 2024;212:145-152.
    PubMed     Abstract available



  98. Gabapentin for Postoperative Pain Control and Opioid Reduction in Scrotal Surgery: A Randomized Controlled Clinical Trial: Erratum.
    J Urol. 2024;212:249.
    PubMed    


    June 2024
  99. CHANG SS
    Urologic Oncology: Bladder, Penis, and Urethral Cancer, and Basic Principles of Oncology.
    J Urol. 2024 Jun 17:101097JU0000000000004092. doi: 10.1097/JU.0000000000004092.
    PubMed    


  100. KAPLAN SA
    Benign Prostatic Hyperplasia.
    J Urol. 2024 Jun 11:101097JU0000000000004083. doi: 10.1097/JU.0000000000004083.
    PubMed    


  101. NIEDERBERGER C
    Male Infertility.
    J Urol. 2024;211:809-811.
    PubMed    


  102. NIEDERBERGER C
    Male Infertility.
    J Urol. 2024;211:814-816.
    PubMed    



  103. Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: AUA GUIDELINE PART I-Initial Work-up and Medical Management: Erratum.
    J Urol. 2024;211:820.
    PubMed    


  104. KAPLAN SA
    Benign Prostatic Hyperplasia.
    J Urol. 2024;211:811-813.
    PubMed    


    May 2024
  105. KAPLAN SA
    Benign Prostatic Hyperplasia.
    J Urol. 2024 May 24:101097JU0000000000003951. doi: 10.1097/JU.0000000000003951.
    PubMed    


  106. KAPLAN SA
    Benign Prostatic Hyperplasia.
    J Urol. 2024 May 17:101097JU0000000000004026. doi: 10.1097/JU.0000000000004026.
    PubMed    


  107. CHANG SS
    Urologic Oncology: Bladder, Penis, and Urethral Cancer, and Basic Principles of Oncology.
    J Urol. 2024 May 17:101097JU0000000000004018. doi: 10.1097/JU.0000000000004018.
    PubMed    


  108. STASKIN D, Owens-Grillo J, Thomas E, Rovner E, et al
    Efficacy and Safety of Vibegron for Persistent Symptoms of Overactive Bladder in Men Being Pharmacologically Treated for Benign Prostatic Hyperplasia: Results From the Phase 3 Randomized Controlled COURAGE Trial.
    J Urol. 2024 May 6:101097JU0000000000003999. doi: 10.1097/JU.0000000000003999.
    PubMed     Abstract available


  109. MOULI S, Salem R, McClure TD
    Prostate Artery Embolization for Benign Prostatic Hyperplasia.
    J Urol. 2024 May 4:101097JU0000000000003976. doi: 10.1097/JU.0000000000003976.
    PubMed    


  110. TROST L
    Reply: Comparison of Collagenase Clostridium histolyticum to Surgery for the Management of Peyronie's Disease: A Randomized Trial.
    J Urol. 2024;211:710-712.
    PubMed    


  111. DESOUKY E, Levine LA
    Letter: Comparison of Collagenase Clostridium histolyticum to Surgery for the Management of Peyronie's Disease: A Randomized Trial.
    J Urol. 2024;211:708-709.
    PubMed    


  112. NIEDERBERGER C
    Male Infertility.
    J Urol. 2024;211:722-723.
    PubMed    


  113. CHANG SS
    Urologic Oncology: Bladder, Penis, and Urethral Cancer, and Basic Principles of Oncology.
    J Urol. 2024;211:720-721.
    PubMed    


  114. CHANG SS
    Urologic Oncology: Bladder, Penis, and Urethral Cancer, and Basic Principles of Oncology.
    J Urol. 2024;211:720-721.
    PubMed    


    April 2024
  115. CHANG SS
    Urologic Oncology: Bladder, Penis, and Urethral Cancer, and Basic Principles of Oncology.
    J Urol. 2024 Apr 22:101097JU0000000000003900. doi: 10.1097/JU.0000000000003900.
    PubMed    


  116. PINKHASOV AM, Viers BR
    Letter: Multi-Institutional Outcomes of Dorsal Onlay Buccal Mucosal Graft Urethroplasty in Patients With Postprostatectomy, Postradiation Anastomotic Stenosis.
    J Urol. 2024 Apr 10:101097JU0000000000003939. doi: 10.1097/JU.0000000000003939.
    PubMed    


  117. TROST L
    Update to the Testosterone Guideline.
    J Urol. 2024;211:608-610.
    PubMed    


  118. NIEDERBERGER C
    Male Infertility.
    J Urol. 2024;211:631-633.
    PubMed    


  119. KAPLAN SA
    Benign Prostatic Hyperplasia.
    J Urol. 2024;211:630-631.
    PubMed    


  120. CHANG SS
    Urological Oncology: Bladder, Penis and Urethra Cancer, and Basic Principles of Oncology.
    J Urol. 2024;211:638-639.
    PubMed    


    March 2024
  121. KAPLAN SA
    Benign Prostatic Hyperplasia.
    J Urol. 2024 Mar 20:101097JU0000000000003872. doi: 10.1097/JU.0000000000003872.
    PubMed    


  122. CHANG SS
    Urologic Oncology: Bladder, Penis, and Urethral Cancer, and Basic Principles of Oncology.
    J Urol. 2024 Mar 15:101097JU0000000000003875. doi: 10.1097/JU.0000000000003875.
    PubMed    


  123. BARKER ES, Chiu K, Brown VL, Morsy H, et al
    Urologic Chronic Pelvic Pain Syndrome Flares: A Comprehensive, Systematic Review and Meta-Analysis of the Peer-Reviewed Flare Literature.
    J Urol. 2024;211:341-353.
    PubMed     Abstract available


  124. NIEDERBERGER C
    Male Infertility.
    J Urol. 2024;211:489-490.
    PubMed    


  125. NESTLER T, Paffenholz P, Pfister D, Schoch J, et al
    Adjunctive Surgery Is Often Without Oncological Benefit at Time of Postchemotherapy Retroperitoneal Lymph Node Dissection.
    J Urol. 2024;211:426-435.
    PubMed     Abstract available


  126. CHANG SS
    Urological Oncology: Bladder, Penis and Urethra Cancer, and Basic Principles of Oncology.
    J Urol. 2024;211:500-501.
    PubMed    


  127. KAPLAN SA
    Benign Prostatic Hyperplasia.
    J Urol. 2024;211:485-487.
    PubMed    


    February 2024
  128. PUNJANI N, Marinaro JA, Kang C, Gal J, et al
    Gabapentin for Post-operative Pain Control and Opioid Reduction in Scrotal Surgery: A Randomized Controlled Clinical Trial.
    J Urol. 2024 Feb 21:101097JU0000000000003884. doi: 10.1097/JU.0000000000003884.
    PubMed     Abstract available


  129. NG L, Kocur OM, Xie P, Cheung S, et al
    Timing of Testicular Biopsy in Relation to Oocyte Retrieval and the Outcomes of Intracytoplasmic Sperm Injection.
    J Urol. 2024 Feb 20:101097JU0000000000003894. doi: 10.1097/JU.0000000000003894.
    PubMed     Abstract available


  130. CHANG KC, Hung SF
    Letter: Serum Testosterone and Dihydrotestosterone and Incidence and Progression of Lower Urinary Tract Symptoms: Results From the REDUCE Study.
    J Urol. 2024 Feb 13:101097JU0000000000003861. doi: 10.1097/JU.0000000000003861.
    PubMed    


  131. DEEBEL N, Ramasamy R
    Letter: Age, Sperm Retrieval, and Testicular Histology in Klinefelter Syndrome.
    J Urol. 2024 Feb 7:101097JU0000000000003867. doi: 10.1097/JU.0000000000003867.
    PubMed    


  132. KAPLAN-MARANS E, Khurgin J
    Letter: Age, Sperm Retrieval, and Testicular Histology in Klinefelter Syndrome.
    J Urol. 2024 Feb 7:101097JU0000000000003868. doi: 10.1097/JU.0000000000003868.
    PubMed    


  133. GREENBERG DR, Panken EJ, Amarasekera C
    Platelet-Rich Plasma for Urologic Conditions: An Early Call for Composition Reporting.
    J Urol. 2024;211:313-316.
    PubMed    


  134. CHANG SS
    Urological Oncology: Bladder, Penis and Urethra Cancer, and Basic Principles of Oncology.
    J Urol. 2024;211:334-335.
    PubMed    


    January 2024
  135. STERLING J, Simhan J, Flynn BJ, Rusilko P, et al
    Multi-Institutional Outcomes of Dorsal Onlay Buccal Mucosal Graft Urethroplasty in Patients With Postprostatectomy, Postradiation Anastomotic Stenosis.
    J Urol. 2024 Jan 26:101097JU0000000000003848. doi: 10.1097/JU.0000000000003848.
    PubMed     Abstract available


  136. CHANG SS
    Urological Oncology: Bladder, Penis and Urethra Cancer, and Basic Principles of Oncology.
    J Urol. 2024 Jan 19:101097JU0000000000003839. doi: 10.1097/JU.0000000000003839.
    PubMed    


  137. KAPLAN SA
    Benign Prostatic Hyperplasia.
    J Urol. 2024 Jan 15:101097JU0000000000003807. doi: 10.1097/JU.0000000000003807.
    PubMed    


  138. O'CONNELL KA, Thomas JL, Murad F, Zhou G, et al
    Total Margin Control Is Superior to Traditional Margin Assessment for Treatment of Low-Stage Penile Squamous Cell Carcinoma.
    J Urol. 2024;211:90-100.
    PubMed     Abstract available


  139. MATULEWICZ RS, Benfante N, Funt SA, Feldman DR, et al
    Primary Retroperitoneal Lymph Node Dissection for Seminoma Metastatic to the Retroperitoneum.
    J Urol. 2024;211:80-89.
    PubMed     Abstract available


    December 2023
  140. CALVO CI, Fender K, Hoy N, Rourke K, et al
    Affirming Long-Term Outcomes after Contemporary Urethroplasty: The Adverse Impact of Increasing Stricture Length, Lichen Sclerosus, Radiation and Infectious Strictures.
    J Urol. 2023 Dec 18:101097JU0000000000003826. doi: 10.1097/JU.0000000000003826.
    PubMed     Abstract available


  141. CHANG SS
    Urological Oncology: Bladder, Penis and Urethra Cancer, and Basic Principles of Oncology.
    J Urol. 2023 Dec 14:101097JU0000000000003806. doi: 10.1097/JU.0000000000003806.
    PubMed    


  142. KAPLAN SA
    Benign Prostatic Hyperplasia.
    J Urol. 2023 Dec 8:101097JU0000000000003762. doi: 10.1097/JU.0000000000003762.
    PubMed    


  143. SEFTEL AD
    Male and Female Sexual Function and Dysfunction; Andrology.
    J Urol. 2023;210:917-918.
    PubMed    


  144. NIEDERBERGER C
    Male Infertility.
    J Urol. 2023;210:915-917.
    PubMed    


    November 2023
  145. CHANG SS
    Urological Oncology: Bladder, Penis and Urethra Cancer, and Basic Principles of Oncology.
    J Urol. 2023 Nov 17:101097JU0000000000003784. doi: 10.1097/JU.0000000000003784.
    PubMed    


  146. KOHN TP, Agrawal P, Ory J, Hare J, et al
    Rises in Hematocrit is Associated with an Increased Risk of Major Adverse Cardiac Events in Men Starting Testosterone Therapy - A Retrospective Cohort Claims Database Analysis.
    J Urol. 2023 Nov 10:101097JU0000000000003786. doi: 10.1097/JU.0000000000003786.
    PubMed     Abstract available


  147. SESSINE MS, Radoiu CS, Qi J, Labardee C, et al
    Can MRI Help Inform Which Men with a History of Multifocal High Grade Prostatic Intraepithelial Neoplasia or Atypical Small Acinar Proliferation Remain at an Elevated Risk for Clinically Significant Prostate Cancer?
    J Urol. 2023 Nov 6:101097JU0000000000003775. doi: 10.1097/JU.0000000000003775.
    PubMed     Abstract available


  148. MASTERSON TA, Molina M, Ledesma B, Zucker I, et al
    Platelet-rich Plasma for the Treatment of Erectile Dysfunction: A Prospective, Randomized, Double-blind, Placebo-controlled Clinical Trial. Reply.
    J Urol. 2023;210:734-735.
    PubMed    


  149. GREEN B, Flores A, Warner J, Kohler T, et al
    Comparison of Collagenase Clostridium histolyticum to Surgery for the Management of Peyronie's Disease: A Randomized Trial.
    J Urol. 2023;210:791-802.
    PubMed     Abstract available


  150. LEE EWC, Antonelli L, Issa A, Churchill J, et al
    Risk of Local Recurrence in Men With Penile Intraepithelial Neoplasia in the Surgical Margin After Penile-sparing Surgery.
    J Urol. 2023;210:778-781.
    PubMed     Abstract available


    October 2023
  151. DANIELS JP, Mirocha J, Adjei M, Moreira D, et al
    Serum Testosterone and Dihydrotestosterone and Incidence and Progression of Lower Urinary Tract Symptoms: Results From the REDUCE Study.
    J Urol. 2023 Oct 24:101097JU0000000000003738. doi: 10.1097/JU.0000000000003738.
    PubMed     Abstract available


  152. KANG C, Punjani N, Kashanian JA, Schlegel PN, et al
    Age, Sperm Retrieval, and Testicular Histology in Klinefelter Syndrome.
    J Urol. 2023 Oct 24:101097JU0000000000003737. doi: 10.1097/JU.0000000000003737.
    PubMed     Abstract available


  153. KAPLAN SA
    Benign Prostatic Hyperplasia.
    J Urol. 2023 Oct 20:101097JU0000000000003731. doi: 10.1097/JU.0000000000003731.
    PubMed    


  154. CHANG SS
    Urologic Oncology: Bladder, Penis, and Urethral Cancer, and Basic Principles of Oncology.
    J Urol. 2023 Oct 18:101097JU0000000000003735. doi: 10.1097/JU.0000000000003735.
    PubMed    


  155. CLENNON EK, Duty B, Seideman C
    Overutilization of Transfer for Testicular Torsion: An Opportunity for Multilevel Policy Intervention.
    J Urol. 2023 Oct 13:101097JU0000000000003750. doi: 10.1097/JU.0000000000003750.
    PubMed    


  156. AYANGBESAN A, Koch GE, Dagostino C, Proctor JM, et al
    Qualitative Analysis of Patient Experiences Reaching Urethroplasty for Recurrent Urethral Stricture Disease.
    J Urol. 2023 Oct 4:101097JU0000000000003722. doi: 10.1097/JU.0000000000003722.
    PubMed     Abstract available


  157. PARK SH, Wilson SK, Wen L
    Subcoronal Incision for Inflatable Penile Prosthesis Does Not Risk Glans Necrosis.
    J Urol. 2023;210:678-687.
    PubMed     Abstract available


    September 2023
  158. CHANG SS
    Urologic Oncology: Bladder, Penis, and Urethral Cancer, and Basic Principles of Oncology.
    J Urol. 2023 Sep 25:101097JU0000000000003719. doi: 10.1097/JU.0000000000003719.
    PubMed    


  159. KAPLAN SA
    Benign Prostatic Hyperplasia.
    J Urol. 2023 Sep 25:101097JU0000000000003714. doi: 10.1097/JU.0000000000003714.
    PubMed    


  160. STEPHENSON A, Bass EB, Bixler BR, Daneshmand S, et al
    Diagnosis and Treatment of Early-Stage Testicular Cancer: AUA Guideline Amendment 2023.
    J Urol. 2023 Sep 14:101097JU0000000000003694. doi: 10.1097/JU.0000000000003694.
    PubMed     Abstract available


  161. SANDHU JS, Bixler BR, Dahm P, Goueli R, et al
    Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia (BPH): AUA Guideline Amendment 2023.
    J Urol. 2023 Sep 14:101097JU0000000000003698. doi: 10.1097/JU.0000000000003698.
    PubMed     Abstract available


  162. KALYVIANAKIS D, Poulios E, Mykoniatis I, Pyrgidis N, et al
    Platelet-rich Plasma for the Treatment of Erectile Dysfunction: A Prospective, Randomized, Double-blind, Placebo-controlled Clinical Trial. Letter.
    J Urol. 2023 Sep 6:101097JU0000000000003684. doi: 10.1097/JU.0000000000003684.
    PubMed    


  163. KAPLAN SA, Moss J, Freedman S, Coutinho K, et al
    The PINNACLE Study: A Double-blind, Randomized, Sham-controlled Study Evaluating the Optilume BPH Catheter System for the Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia.
    J Urol. 2023;210:500-509.
    PubMed     Abstract available


  164. NIEDERBERGER C
    Male Infertility.
    J Urol. 2023;210:553-555.
    PubMed    


  165. SEFTEL AD
    Male and Female Sexual Function and Dysfunction; Andrology.
    J Urol. 2023;210:555-556.
    PubMed    


  166. FRENDL DM, Chou WH, Chen YW, Chang DC, et al
    Early vs Delayed Transurethral Surgery in Acute Urinary Retention: Does Timing Make a Difference?
    J Urol. 2023;210:492-499.
    PubMed     Abstract available


  167. RAGUE JT, Hirsch J, Meyer T, Streur C, et al
    "I Just Haven't Done Any of That": Applicability of the International Index of Erectile Function in Young Men With Spina Bifida.
    J Urol. 2023;210:538-547.
    PubMed     Abstract available


    August 2023
  168. CHANG SS
    Urologic Oncology: Bladder, Penis, and Urethral Cancer, and Basic Principles of Oncology.
    J Urol. 2023 Aug 24:101097JU0000000000003660. doi: 10.1097/JU.0000000000003660.
    PubMed    


  169. KAPLAN SA
    Benign Prostatic Hyperplasia.
    J Urol. 2023 Aug 23:101097JU0000000000003665. doi: 10.1097/JU.0000000000003665.
    PubMed    


  170. STANIORSKI CJ, Myrga JM, Vasan RV, Klein RD, et al
    Surgical outcomes and prediction of complications following high complexity buried penis reconstruction.
    J Urol. 2023 Aug 16:101097JU0000000000003669. doi: 10.1097/JU.0000000000003669.
    PubMed     Abstract available


  171. KAPLAN-MARANS E, Marans H
    Impact of Prostate Urethral Lift Device on Prostate Magnetic Resonance Image Quality. Letter.
    J Urol. 2023;210:251-252.
    PubMed    


  172. SEFTEL AD
    Male and Female Sexual Function and Dysfunction; Andrology.
    J Urol. 2023;210:368-370.
    PubMed    


  173. DI H, Wen Y
    Does Preoperative Testosterone Administration Decrease Complications in Distal Hypospadias Repair With Urethroplasty? Letter.
    J Urol. 2023 Aug 1:101097JU0000000000003636. doi: 10.1097/JU.0000000000003636.
    PubMed    


  174. CHANG SS
    Urologic Oncology: Bladder, Penis, and Urethral Cancer, and Basic Principles of Oncology.
    J Urol. 2023 Aug 1:101097JU0000000000003630. doi: 10.1097/JU.0000000000003630.
    PubMed    


    July 2023
  175. KAPLAN SA
    Benign Prostatic Hyperplasia.
    J Urol. 2023 Jul 25:101097JU0000000000003622. doi: 10.1097/JU.0000000000003622.
    PubMed    


  176. GODLEWSKI K, Mittal S, Long C
    Does Preoperative Testosterone Administration Decrease Complications in Distal Hypospadias Repair With Urethroplasty? Reply.
    J Urol. 2023 Jul 14:101097JU0000000000003608. doi: 10.1097/JU.0000000000003608.
    PubMed    


  177. MOSA H
    Does Preoperative Testosterone Administration Decrease Complications in Distal Hypospadias Repair With Urethroplasty? Letter.
    J Urol. 2023 Jul 6:101097JU0000000000003607. doi: 10.1097/JU.0000000000003607.
    PubMed    


  178. SEFTEL AD
    Male and Female Sexual Function and Dysfunction; Andrology.
    J Urol. 2023;210:206-207.
    PubMed    


  179. NIEDERBERGER C
    Male Infertility.
    J Urol. 2023;210:204-206.
    PubMed    


    June 2023
  180. CHANG SS
    Urologic Oncology: Bladder, Penis, and Urethral Cancer, and Basic Principles of Oncology.
    J Urol. 2023 Jun 19:101097JU0000000000003577. doi: 10.1097/JU.0000000000003577.
    PubMed    


  181. RICHIE JP
    Urologic Oncology: Testis Cancer and Advances in Oncologic Therapy.
    J Urol. 2023 Jun 19:101097JU0000000000003588. doi: 10.1097/JU.0000000000003588.
    PubMed    


  182. KAPLAN SA
    Benign Prostatic Hyperplasia.
    J Urol. 2023 Jun 15:101097JU0000000000003580. doi: 10.1097/JU.0000000000003580.
    PubMed    


  183. SEFTEL AD
    Male and Female Sexual Function and Dysfunction; Andrology.
    J Urol. 2023;209:1218-1221.
    PubMed    


  184. NIEDERBERGER C
    Male Infertility.
    J Urol. 2023;209:1216-1218.
    PubMed    


  185. STEPHENS-SHIELDS AJ, Lai HH, Landis JR, Kreder K, et al
    Clinically Important Differences for Pain and Urinary Symptoms in Urological Chronic Pelvic Pain Syndrome: A MAPP Network Study.
    J Urol. 2023;209:1132-1140.
    PubMed     Abstract available


    May 2023
  186. RICHIE JP
    Urologic Oncology: Testis Cancer and Advances in Oncologic Therapy.
    J Urol. 2023 May 18:101097JU0000000000003542. doi: 10.1097/JU.0000000000003542.
    PubMed    


  187. GODLEWSKI KF, Mittal S, Hyacinthe N, Fischer K, et al
    Does Preoperative Testosterone Administration Decrease Complications in Distal Hypospadias Repair with Urethroplasty?
    J Urol. 2023 May 17:101097JU0000000000003548. doi: 10.1097/JU.0000000000003548.
    PubMed     Abstract available


  188. CHANG SS
    Urologic Oncology: Bladder, Penis, and Urethral Cancer, and Basic Principles of Oncology.
    J Urol. 2023 May 17:101097JU0000000000003540. doi: 10.1097/JU.0000000000003540.
    PubMed    


  189. KAPLAN SA
    Benign Prostatic Hyperplasia.
    J Urol. 2023 May 9:101097JU0000000000003522. doi: 10.1097/JU.0000000000003522.
    PubMed    


  190. RICHIE JP
    Urologic Oncology: Testis Cancer and Advances in Oncologic Therapy.
    J Urol. 2023 May 2:101097JU0000000000003474. doi: 10.1097/JU.0000000000003474.
    PubMed    


  191. SEFTEL AD
    Male and Female Sexual Function and Dysfunction; Andrology.
    J Urol. 2023;209:1013-1014.
    PubMed    


  192. RICHIE JP
    Urologic Oncology: Testis Cancer and Advances in Oncologic Therapy.
    J Urol. 2023;209:1028-1029.
    PubMed    


  193. DAVARO F, Spiess PE
    Enlisting Urologists to Improve Palliative Care Services Integration in the Care of Advanced Penile Cancer.
    J Urol. 2023;209:824-826.
    PubMed    


  194. CHANG SS
    Urologic Oncology: Bladder, Penis, and Urethral Cancer, and Basic Principles of Oncology.
    J Urol. 2023;209:1025-1026.
    PubMed    


  195. RIVERO MJ, Ory J, Diaz P, Thirumavalavan N, et al
    Comparison of Hematocrit Change in Testosterone-Deficient Men Treated With Intranasal Testosterone Gel vs Intramuscular Testosterone Cypionate: A Randomized Clinical Trial.
    J Urol. 2023 May 1:101097JU0000000000003487. doi: 10.1097/JU.0000000000003487.
    PubMed     Abstract available


    April 2023
  196. MASTERSON TA, Molina M, Ledesma B, Zucker I, et al
    Platelet-rich Plasma for the Treatment of Erectile Dysfunction: A Prospective, Randomized, Double-blind, Placebo-controlled Clinical Trial.
    J Urol. 2023 Apr 30:101097JU0000000000003481. doi: 10.1097/JU.0000000000003481.
    PubMed     Abstract available


  197. BHOJANI N, Bidair M, Kramolowsky E, Desai M, et al
    Aquablation Therapy in Large Prostates (80-150 mL) for Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia: Final WATER II 5-Year Clinical Trial Results.
    J Urol. 2023 Apr 28:101097JU0000000000003483. doi: 10.1097/JU.0000000000003483.
    PubMed     Abstract available


  198. CHANG SS
    Urologic Oncology: Bladder, Penis, and Urethral Cancer, and Basic Principles of Oncology.
    J Urol. 2023 Apr 27:101097JU0000000000003465. doi: 10.1097/JU.0000000000003465.
    PubMed    


  199. KAPLAN SA
    Benign Prostatic Hyperplasia.
    J Urol. 2023 Apr 20:101097JU0000000000003470. doi: 10.1097/JU.0000000000003470.
    PubMed    


  200. TUTOLO M, Briganti A, Salonia A, Montorsi F, et al
    Role of Antimuscarinics Combined With Alpha-blockers in the Management of Urinary Storage Symptoms in Patients With Benign Prostatic Hyperplasia: An Updated Systematic Review and Meta-analysis.
    J Urol. 2023 Apr 13:101097JU0000000000003484. doi: 10.1097/JU.0000000000003484.
    PubMed    


  201. LENFANT L, Pinar U, Roupret M, Mozer P, et al
    RE: RE: Role of Antimuscarinics Combined With Alpha-blockers in the Management of Urinary Storage Symptoms in Patients With Benign Prostatic Hyperplasia: An Updated Systematic Review and Meta-analysis.
    J Urol. 2023 Apr 13:101097JU0000000000003485. doi: 10.1097/JU.0000000000003485.
    PubMed    


  202. SEFTEL AD
    Male and Female Sexual Function and Dysfunction; Andrology.
    J Urol. 2023;209:795-797.
    PubMed    


  203. NIEDERBERGER C
    Male Infertility.
    J Urol. 2023;209:793-794.
    PubMed    


    March 2023
  204. RICHIE JP
    Urologic Oncology: Testis Cancer and Advances in Oncologic Therapy.
    J Urol. 2023 Mar 23:101097JU0000000000003419. doi: 10.1097/JU.0000000000003419.
    PubMed    


  205. KAPLAN SA
    Benign Prostatic Hyperplasia.
    J Urol. 2023 Mar 23:101097JU0000000000003415. doi: 10.1097/JU.0000000000003415.
    PubMed    


  206. CHANG SS
    Urologic Oncology: Bladder, Penis, and Urethral Cancer, and Basic Principles of Oncology.
    J Urol. 2023 Mar 23:101097JU0000000000003411. doi: 10.1097/JU.0000000000003411.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Andrology is free of charge.

Privacy / Datenschutzerklärung | Imprint / Impressum